Advertisement

Product › Details
Kymriah®
![]() |
Next higher product group | tisagenlecleucel-T (CTL019) |
![]() |
Status | 2017-08-30 registration start |
![]() |
Organisation | Novartis AG (NYSE: NVS) |
Group | Novartis (Group) | |
Organisation 2 | Oxford Biomedica plc (LSE: OXB) | |
Group | Oxford Biomedica (Group) | |
Original research | University of Pennsylvania (UPenn) | |
Record changed: 2024-06-07 |
Advertisement

More documents for CAR T-cell therapy product
- [1] Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel....
- [2] Capstan Therapeutics, Inc.. (3/20/24). "Press Release: Capstan Therapeutics Announces $175M Oversubscribed Series B Financing". San Diego, CA....
- [3] BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London....
- [4] Legend Biotech Corporation. (11/13/23). "Press Release: Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3". Somerset, NJ....
- [5] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (9/21/23). "Press Release: Starting Up with Highly Promising Immunotherapies"....
- [6] Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna....
- [7] T-Curx GmbH. (8/28/23). "Press Release: T-Curx GmbH Announces Appointment of Two Industry Leaders to Its Board of Directors"....
- [8] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (5/26/23). "Press Release: €4.6 Million for a Novel CAR T-cell Therapy". Berlin....
- [9] CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA....
- [10] Friedrich-Alexander-Universität Erlangen-Nürnberg. (2/20/23). "Press Release: Testing Their Strength –CAR T-cells Combat Muscle Inflammation. Universitätsklinikum Erlangen the First in the World to Use a Pioneering New Method to Successfully Treat a ...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top